A RANDOMIZED PHASE II STUDY (GISL-MM03 TRIAL) WITH ORAL MELPHALAN plus PREDNISONE (MP) VERSUS MELPHALAN, plus PREDNISONE plus THALIDOMIDE (MPT) FOR NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMAStefano Sacchi, Maura Brugiatelli, O. Ciarcia et al.|IRIS UNIMORE (University of Modena and Reggio Emilia)|2009Cited by 1